Nico Bruining

Dr. Nico Bruining

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2011 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
HGHector M. Garcìa-Garcìa
Hector M. Garcìa-Garcìa
BGBill D. Gogas
Bill D. Gogas
PSPatrick W. Serruys
Patrick W. Serruys
NBNico Bruining
Nico Bruining
Gray-scale intravascular ultrasound (IVUS) is the modality that has been established as the golden standard for in vivo imaging of the vessel wall of the coronary arteries. The use of IVUS in clinical practice is an important diagnostic tool used for quantitative assessment of coronary artery disease. This has made IVUS the de-facto invasive imaging method to evaluate new interventional therapies such as new stent designs and for atherosclerosis progression-regression studies. However, the gray-scale representation of the coronary vessel wall and plaque morphology in combination with the limited resolution of the current IVUS catheters makes it difficult, if not impossible, to identify qualitatively (e.g. visually) the plaque morphology similar as that of histopathology, the golden standard to characterize and quantify coronary plaque tissue components. Meanwhile, this limitation has been partially overcome by new innovative IVUS-based post-processing methods such as: virtual histology IVUS (VH-IVUS, Volcano Therapeutics, Rancho Cordova, CA, USA), iMAP-IVUS (Bostoc Scientific, Santa Clara, CA, USA), Integrated Backscatter IVUS (IB-IVUS) and Automated Differential Echogenicity (ADE).

26 May 2022 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MSMaarten van Smeden
Maarten van Smeden
Georg HeinzeGeorg Heinze
Georg Heinze
BCBen Van Calster
Ben Van Calster
FAFolkert W Asselbergs
Folkert W Asselbergs
PVPanos E Vardas
Panos E Vardas
KMKarel G M Moons
Karel G M Moons
The medical field has seen a rapid increase in the development of artificial intelligence (AI)-based prediction models. With the introduction of such AI-based prediction model tools and software in cardiovascular patient care, the cardiovascular researcher and healthcare professional are challenged to understand the opportunities as well as the limitations of the AI-based predictions. In this article, we present 12 critical questions for cardiovascular health professionals to ask when confronted with an AI-based prediction model. We aim to support medical professionals to distinguish the AI-based prediction models that can add value to patient care from the AI that does not.

6 June 2024 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Open access
KNKoen Nieman
Koen Nieman
HGHéctor M. Garcia Garcia
Héctor M. Garcia Garcia
AHAlexandre Hideo-Kajita
Alexandre Hideo-Kajita
CCCarlos Collet
Carlos Collet
DDDamini Dey
Damini Dey
SAStephan Achenbach
Stephan Achenbach
In current clinical practice, qualitative or semi-quantitative measures are primarily used to report coronary artery disease on cardiac CT. With advancements in cardiac CT technology and automated post-processing tools, quantitative measures of coronary disease severity have become more broadly available. Quantitative coronary CT angiography has great potential value for clinical management of patients, but also for research. This document aims to provide definitions and standards for the performance and reporting of quantitative measures of coronary artery disease by cardiac CT.

25 August 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
ESEmma Svennberg
Emma Svennberg
Enrico Gianluca CaianiEnrico Gianluca Caiani
Enrico Gianluca Caiani
NBNico Bruining
Nico Bruining
LDLien Desteghe
Lien Desteghe
JHJanet K Han
Janet K Han
DDDavid Duncker
David Duncker
Aims: Over the past 25 years there has been a substantial development in the field of digital electrophysiology (EP) and in parallel a substantial increase in publications on digital cardiology. In this celebratory paper, we provide an overview of the digital field by highlighting publications from the field focusing on the EP Europace journal. Results: In this journey across the past quarter of a century we follow the development of digital tools commonly used in the clinic spanning from the initiation of digital clinics through the early days of telemonitoring, to wearables, mobile applications, and the use of fully virtual clinics. We then provide a chronicle of the field of artificial intelligence, a regulatory perspective, and at the end of our journey provide a future outlook for digital EP. Conclusion: Over the past 25 years Europace has published a substantial number of papers on digital EP, with a marked expansion in digital publications in recent years.

12 October 2024 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
NSNiels Tjeerd Benjamin Scholte
Niels Tjeerd Benjamin Scholte
ARAnnemiek. E. van Ravensberg
Annemiek. E. van Ravensberg
ASAbdul Shakoor
Abdul Shakoor
EBEric Boersma
Eric Boersma
EREelko Ronner
Eelko Ronner
RBRobert M. A. van der Boon
Robert M. A. van der Boon
Wearables offer a promising solution for enhancing remote monitoring (RM) of heart failure (HF) patients by tracking key physiological parameters. Despite their potential, their clinical integration faces challenges due to the lack of rigorous evaluations. This review aims to summarize the current evidence and assess the readiness of wearables for clinical practice using the Medical Device Readiness Level (MDRL). A systematic search identified 99 studies from 3112 found articles, with only eight being randomized controlled trials. Accelerometery was the most used measurement technique. Consumer-grade wearables, repurposed for HF monitoring, dominated the studies with most of them in the feasibility testing stage (MDRL 6). Only two of the described wearables were specifically designed for HF RM, and received FDA approval. Consequently, the actual impact of wearables on HF management remains uncertain due to limited robust evidence, posing a significant barrier to their integration into HF care.

11 June 2009 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
KSKenji Sihan
Kenji Sihan
CBCharl Botha
Charl Botha
FPFrits Post
Frits Post
SWSebastiaan de Winter
Sebastiaan de Winter
NGNieves Gonzalo
Nieves Gonzalo
NBNico Bruining
Nico Bruining